Clinical Trial Update: A First-in-Human Study of SBP-9330 in Healthy Subjects [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of SBP-9330 in healthy subjects for smoking cessation completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• SBP-9330

Snippet

Sponsor: Camino Pharma, LLC | Conditions: Smoking Cessation | Phase 1 | Status: COMPLETED | Results posted: 2024-04-16